239 related articles for article (PubMed ID: 35432196)
1. Identification of the Shared Gene Signatures and Biological Mechanism in Type 2 Diabetes and Pancreatic Cancer.
Hu Y; Zeng N; Ge Y; Wang D; Qin X; Zhang W; Jiang F; Liu Y
Front Endocrinol (Lausanne); 2022; 13():847760. PubMed ID: 35432196
[TBL] [Abstract][Full Text] [Related]
2. Exploring Shared Pathogenesis of Alzheimer's Disease and Type 2 Diabetes Mellitus via Co-expression Networks Analysis.
Zhu Y; Ding X; She Z; Bai X; Nie Z; Wang F; Wang F; Geng X
Curr Alzheimer Res; 2020; 17(6):566-575. PubMed ID: 32781959
[TBL] [Abstract][Full Text] [Related]
3. Identification of metabolism genes related to hepatocarcinogenesis and progression in type 2 diabetes mellitus via co-expression networks analysis.
Bi Y; Yin B; Fan G
Hereditas; 2021 Apr; 158(1):14. PubMed ID: 33865459
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential biological processes and key genes in diabetes-related stroke through weighted gene co-expression network analysis.
He Y; Bai Y; Huang Q; Xia J; Feng J
BMC Med Genomics; 2024 Jan; 17(1):8. PubMed ID: 38166912
[TBL] [Abstract][Full Text] [Related]
5. Identification of Up-Regulated ANXA3 Resulting in Fracture Non-Union in Patients With T2DM.
Liu C; Liu Y; Yu Y; Zhao Y; Zhang D; Yu A
Front Endocrinol (Lausanne); 2022; 13():890941. PubMed ID: 35813617
[TBL] [Abstract][Full Text] [Related]
6. CD8
Dai C; Wang D; Tao Q; Li Z; Zhai P; Wang Y; Hou M; Cheng S; Qi W; Zheng L; Yao H
Front Immunol; 2024; 15():1267963. PubMed ID: 38464509
[TBL] [Abstract][Full Text] [Related]
7. Identification of the shared gene signature and biological mechanism between type 2 diabetes and colorectal cancer.
Liu X; Li D; Gao W; Zhao W; Jin L; Chen P; Liu H; Zhao Y; Dong G
Front Genet; 2023; 14():1202849. PubMed ID: 37876593
[No Abstract] [Full Text] [Related]
8. Gene expression profiling and protein-protein network analysis revealed prognostic hub biomarkers linking cancer risk in type 2 diabetic patients.
Kasera H; Shekhawat RS; Yadav P; Singh P
Sci Rep; 2023 Dec; 13(1):22605. PubMed ID: 38114687
[TBL] [Abstract][Full Text] [Related]
9. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer.
Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y
BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300
[TBL] [Abstract][Full Text] [Related]
10. Identification of Potential Biomarkers of Type 2 Diabetes Mellitus-Related Immune Infiltration Using Weighted Gene Coexpression Network Analysis.
Zhou J; Zhang X; Ji L; Jiang G
Biomed Res Int; 2022; 2022():9920744. PubMed ID: 35187175
[TBL] [Abstract][Full Text] [Related]
11. Exploration of the Shared Gene Signatures and Molecular Mechanisms Between Systemic Lupus Erythematosus and Pulmonary Arterial Hypertension: Evidence From Transcriptome Data.
Yao M; Zhang C; Gao C; Wang Q; Dai M; Yue R; Sun W; Liang W; Zheng Z
Front Immunol; 2021; 12():658341. PubMed ID: 34335565
[TBL] [Abstract][Full Text] [Related]
12. Genetic association between major depressive disorder and type 2 diabetes mellitus: Shared pathways and protein networks.
Liu D; McIntyre RS; Li R; Yang M; Xue Y; Cao B
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110339. PubMed ID: 33915220
[TBL] [Abstract][Full Text] [Related]
13. Identification of the shared gene signatures and pathways between sarcopenia and type 2 diabetes mellitus.
Huang S; Xiang C; Song Y
PLoS One; 2022; 17(3):e0265221. PubMed ID: 35271662
[TBL] [Abstract][Full Text] [Related]
14. Exploration of shared gene signatures and molecular mechanisms between type 2 diabetes and osteoporosis.
Du A; Xu R; Yang Q; Lu Y; Luo X
J Cell Mol Med; 2024 May; 28(9):e18141. PubMed ID: 38742851
[TBL] [Abstract][Full Text] [Related]
15. LncRNAs associated with vascular mimicry establish a novel molecular subtype and prognostic model for pancreatic cancer.
Li D; Zhang Q; Tang Y; Mao F; Zeng J; Ji A
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11571-11584. PubMed ID: 37400573
[TBL] [Abstract][Full Text] [Related]
16. Identification of the shared gene signatures and molecular mechanisms between multiple sclerosis and non-small cell lung cancer.
Yang J; Hu X; Wang Y; Liu W; Zhang M; Zhang A; Ni B
Front Immunol; 2023; 14():1180449. PubMed ID: 37251402
[TBL] [Abstract][Full Text] [Related]
17. Integrated Analyses Identify Immune-Related Signature Associated with Qingyihuaji Formula for Treatment of Pancreatic Ductal Adenocarcinoma Using Network Pharmacology and Weighted Gene Co-Expression Network.
Qian X; Chen Z; Chen SS; Liu LM; Zhang AQ
J Immunol Res; 2020; 2020():7503605. PubMed ID: 32537471
[TBL] [Abstract][Full Text] [Related]
18. Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis.
Wang Y; Kong Y; Yang Q; Zhong C; Zhou D
Eur J Med Res; 2024 Apr; 29(1):221. PubMed ID: 38581008
[TBL] [Abstract][Full Text] [Related]
19. Identification of key genes and molecular pathways in type 2 diabetes mellitus and polycystic ovary syndrome via bioinformatics analyses.
Zhang J; Zhang FJ; Zhang L; Xian DX; Wang SA; Peng M; Liu Y
Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3255-3269. PubMed ID: 37140276
[TBL] [Abstract][Full Text] [Related]
20. Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancer.
Ma X; Tao R; Li L; Chen H; Liu Z; Bai J; Shuai X; Wu C; Tao K
Oncol Rep; 2019 Jan; 41(1):292-300. PubMed ID: 30365134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
